BV Pundit Chyavanprasha
Chyavanprasha (200 gms)
275.00 Add to Cart

Chyavanprasha (200 gms)

275.00

(C. S.- Modified)
Chief Ingredients: Mandookaparni, Bhringaraja, Amalaki, Yestimadhu, Sungandhamaricha, Trikatu. Pushkaramula, Kasisa. Sariva.

  Request a Callback
Buy Now

BV Pundit Chyavanprasha is an Ayurvedic Dietary Supplement prepared by ancient methods. It stands at the forefront of Rejuvenation supplements and therapies. Rejuvenation and revitalizing the body have become a very important step toward a healthy life in today’s hectic lifestyle. It is the specific medicine for acute and chronic asthma and cough.

It is a respiratory tonic with a rich and reliable vitamin “C” of Amalaka which is the main ingredient, The classics quote that Chyavana Maharishi got back his youth by using this preparation. Though this claim is exaggerated it is true that it prevents weakness that results from aging.

BV Pundit Chyavanprasha is one of the anti-ageing supplements, which is purely herbal in nature. It has Amla as its main ingredient, which is a powerful antioxidant.  Master Charaka is the first to mention this herbal medicine.

Indication: Chyavanprash is the specific medicine for acute and chronic asthma and cough. It is a respiratory tonic with a rich and reliable vitamin C of Amalaka whjch is the main ingredient. The classics quote that Chyavana Maharishi got back his youth by using this preparation. Though this claim may be exaggerated, it is true that it prevents weakness which results from ageing.

Direction of Use : 6g (one teaspoon) to be rolled into a small marble sized ball and consumed.

NOTES : Minimum of two glasses of milk is to be consumed per day when on Chyavanprash.

Click here for more Ayurvedic Medicine : Ayurvedic Medicine

Additional information

Weight

200 Grms

Reviews

There are no reviews yet.

Be the first to review “Chyavanprasha (200 gms)”

Your email address will not be published. Required fields are marked *

No more offers for this product!

General Inquiries

There are no inquiries yet.